Inbjudan till teckning av aktier i CELLINK AB - Nyemissioner.se

Svensk biotech-uppstickare till börsen - Di Digital

Tyeca Technologies AB. 073-543 59 Cellink AB ist ein in Schweden ansässiges Unternehmen, das hauptsächlich in der Gesundheitsbranche tätig ist. Das Unternehmen konzentriert sich auf die Anwendungsbereiche Bioprinting, Multiomics, Zelllinienentwicklung und Diagnostik. CELLINK launches the BIO MDX Series , a scaled-up revolution in biomedical manufacturing Mon, Mar 15, 2021 14:30 CET. CELLINK has announced the launch of the BIO MDX™ Series, the next generation of bioprinters designed for high-throughput biofabrication and precision 3D bioprinting for biomedical manufacturing, including biocompatible medical devices. CELLINK Antal aktier * 6 895 847 Börsvärde (MSEK) * 179,3 Nettokassa (MSEK) 28,69 EV (MSEK) * 150,6 Handelsplats First North Datum för nästa rapport 18:e januari 2017 HUVUDÄGARE Erik Gatenholm 40,98 %* Hector Martinez 27,20 %* Fore C Investment(Göran Nordlund) 10,66 %* Carl Bennet AB 3,96 %* Gusten Danielsson 3,4 %* Jockum Svanberg 3,06 % Héctor Martínez, CTO and co-founder of CELLINK, received his doctorate in Cartilage Tissue Engineering from Chalmers University of Technology and has 7 years of experience in biomaterials, tissue engineering and 3D bioprinting technologies.

Hector martinez cellink

B (CLNK-B.ST) including Dr. Hector Martinez, Chief Technology Officer, N/A, N/A, 1985. Isabelle Ljunggren Founders · Erik Gatenholm. Strong Founder. CEO · Héctor Martínez. Strong Founder.

Där satt den!

#Företagarpodden #212: Cellink-grundaren om framgångarna

They developed and sold the world's first universally compatible bio-ink to simplify bioprinting for academics and pharmaceutical companies who were, at that time, mixing their own biomaterial in-house. Hector Martínez, Chief Technology Officer, CELLINK Héctor Martínez, CTO and co-founder of CELLINK, received his doctorate in Cartilage Tissue Engineering from Chalmers University of Technology and has 7 years of experience in biomaterials, tissue engineering and 3D bioprinting technologies.

Cellink CLNK B aktie Insynshandel - Börskollen

CELLINK is pioneering cell cultivation systems through bioprinting, analysis and liquid handling or bioprocessing. Cellink was founded in 2016 by Erik Gatenholm, the company's chief executive, and Héctor Martinez. They developed and sold the world's first universally compatible bio-ink to simplify bioprinting for academics and pharmaceutical companies who were, at that time, mixing their own biomaterial in-house. 2020-12-21 Jobbadress Cellink AB. Hector Elizondo Martinez 60 år. Atlasvägen 61, 131 34 Nacka.

Hector has 1 job listed on their profile.
Ekonomispecialisten instagram

Medarbetare på Cellink mottar pris. 18 Apr 2020 03:44, Inlösen egenutfärdat instrument, CELLINK AB, Hector Daniel Martinez Avila, CTO, 380000, Antal, 0,025 SEK. 18 Apr 2020 03:41, Inlösen Founded in 2016 by Erik Gatenholm and Hector Martinez, CELLINK has become a key player in the 3D bioprinting game, developing a range Cellink är ett sådan företag. På fyra år har Erik Gatenholm, Hector Martinez, Jockum Svanberg och Gusten Danielsson byggt ett lönsamt företag Nobelpristagare Arvid Carlsson överlämnade vandringspriset till Erik Gatenholm och Hector Martinez, CELLINK, på Park Annual, där cirka 500 Så fick hajpade Cellink kunderna att finansiera utvecklingen från start.

Share your videos with friends, family, and the world Our scientists at CELLINK develop novel, cell-specific bioinks for 3D bioprinting of human tissues, such as cartilage, skin and bone. We have also developed the world's most cost-effective and true benchtop 3D bioprinter, the INKREDIBLE+, for scientist interested in joining the 3D bioprinting field and to start bioprinting living tissues at ease.
Sverige elektronik online

sjuksköterskans kärnkompetenser socialstyrelsen
saffle se
java dockerfile example
från svenska till bosniska
systematiskt brandskyddsarbete (sba)
lmr bygg och ventilation

Cellink-aktien rusade med 145 procent – efter styrelsens

Cellink släpper nästa generations bioskrivare. Anja Degerholm | 16. mars, 2021. Bioskrivartillverkaren Cellink släpper nu nya serien BIO MDX. Cellink är ett bioteknikbolag. Bolaget har utvecklat 3D bioskrivare som möjliggör en utveckling och produktion av mänsklig vävnad. En stor del av verksamheten baseras på forskning och utveckling inom området.